B
cells play pivotal roles in humoral immunity and are a key component of the immune system. Like other blood cell types, mature B cells arise from self-renewing pluripotent hematopoietic stem cells (HSCs) through a stepwise process involving coordinated cell proliferation along with progressive lineage commitment and differentiation. In the B cell lineage, HSCs first develop into lymphoid-primed multipotent progenitors, which have lost their self-renewal ability but remain multipotent, and then into common lymphocyte progenitors (CLPs), which in turn develop into B cells, T cells, NK cells, and dendritic cells (1) . The first B cell-specific progenitors arising from CLPs are prepro-B cells, which sequentially develop into pro-B, pre-B, immature, and ultimately mature B cells.
B cell development requires appropriate orchestration of a network of regulatory genes involved in cell survival, proliferation, and differentiation (2, 3) . Particularly in early B cell development, several key transcription factors act in a hierarchical order to precisely control the expression of critical genes (4, 5) . Pu.1 is involved in the hematopoietic lineage fate decision at the branchpoint of myeloerythroid and myelolymphoid progenitor populations (6) . Ikaros is a key factor in B lineage specification and commitment. Ikaros-deficient or hypomorphic mutant mice have severe defects in the development of the lymphoid system (7, 8) . Ebf1 and Pu.1 activate IL-7R, the first gene that distinguishes CLPs from lymphoid-primed multipotent progenitors (9) (10) (11) . E2A functions upstream of EBF, and the two transcription factors collaborate to activate Pax5 expression (12, 13) . Pax5 is indispensable in B cell lineage commitment in that it activates B lineage-specific genes and represses lineage-inappropriate genes (14, 15) .
Programmed cell death frequently occurs during B cell development, but despite intensive studies, the molecular mechanisms that control this process are still elusive. Accumulating evidence has demonstrated that members of the Bcl2 protein family, including Bcl2 (16) , Bcl-xL (17, 18) , Mcl1 (19) , Bax (20) , Bik (21) , and Bim (22) , are critical for B cell survival in vivo and in vitro.
Other factors, such as Stat5 and Dicer1, are also involved in maintaining B cell survival. Stat5 has been shown to mediate the survival function of IL-7 signaling during B cell development (23, 24) . Conditional deletion of Dicer1 in the earliest stage of B cell development results in an almost complete absence of pre-B cells, owing to a massive increase in apoptosis in pre-B cells (25, 26) . In adult mice, signaling by stem cell factor and its receptor c-Kit is critical in pro-B and pro-T cell development (27) . The downstream signaling pathways activated by c-Kit include activation of PI3K and Src kinase. However, c-Kit-mediated Src kinase activation, but not PI3K activation, is important for adult B cell development, likely through signaling events related to cell proliferation and cell survival (28) .
Sox4 is a member of the SOX (SRY-related HMG box) transcription factor family and has been shown to play important roles in embryonic development and differentiation (29) . Germline deletion of Sox4 is embryonically lethal in mice (30) . Embryos with this deletion died at day 14 of development owing to circu-lation failure as a result of malformation of the semilunar valves and ventricular septum. In vitro culture of liver cells from Sox4 Sox4 has since been shown to be critical for cell survival and differentiation in many cell lineages other than B cells in embryonic development and postnatal life, and to act largely in redundancy with its close relatives Sox11 and Sox12 (31) (32) (33) (34) (35) . In this study, we used Sox4 fl/fl mice and Vav-Cre recombinase to investigate the effect of Sox4 deletion in HSCs on B cell development. Our results showed that Sox4 was essential for pro-B cell survival and might functionally interact with c-Kit and Bcl2.
Materials and Methods

Mice
Mice with loxP sites flanking the entire coding region of the Sox4 gene were described previously (36) . Vav-Cre mice were provided by Dr. Dimitris Kioussis at the National Institute for Medical Research, The Ridgeway, London (37) . H2K-Bcl2 transgenic (Tg) mice were provided by Dr. Irving Weissman at Stanford University, Stanford, CA (38) . Genotyping was performed by PCR, using genomic DNA extracted from mouse tails. All mice were bred and maintained in a specific pathogen-free animal facility at The University of Texas MD Anderson Cancer Center, Houston, TX. All mouse experiments were performed in accordance with federal laws as well as guidelines of the National Institutes of Health, and protocols were approved by the MD Anderson Animal Care and Use Committee.
Imatinib treatment
To inhibit the c-Kit signaling pathway, 4-to 5-wk-old mice were given i.p. injections of 100 mg/kg imatinib (LC Laboratories, Woburn, MA) twice daily in a volume of 100 ml PBS for 2, 3, or 7 consecutive days, as indicated. Mice were euthanized the day after the last injection, and samples were harvested for flow cytometric analysis.
Cell surface staining, flow cytometry, and cell sorting Single-cell suspensions were prepared at the time of autopsy from fetal liver, bone marrow (femurs and tibias), and spleen. All samples were incubated with ice-cold RBC lysis buffer with ammonium chloride for 4 min in the dark before staining with a combination of mouse-specific Abs at 4˚C for 15 min in staining solution (PBS supplemented with 1% BSA). Blood was collected from the hearts of the mice in 15-ml Falcon tubes (Becton-Dickinson Biosciences, San Jose, CA) containing 50 ml 0.5 M EDTA in PBS. After two rounds of RBC lysis, the WBCs were subjected to staining.
Abs used for flow cytometric analysis included the following: 
Annexin V and intracellular staining
For cell apoptosis analysis, the staining buffers containing surface Abs were carefully removed before biotin-conjugated Annexin V was applied according to the manufacturer's instructions (Becton-Dickinson Biosciences). For intracellular detection of Bcl2 (2870), total Src (2109), or p-Src (2101; Cell Signaling Technology, Danvers, MA), cells were incubated with surface Abs as indicated. After being washed with staining solution, cells were incubated in fixation solution (00-8222-49; eBioscience) for 20 min and subsequently washed twice with permeabilization buffer (00-8333-56; eBioscience). Cells were then incubated with specific primary Abs for 30 min at room temperature and then incubated for 20 min on ice with PE-, allophycocyanin-, or FITC-conjugated anti-rabbit second Abs.
Semiquantitative RT-PCR
Total RNA was isolated from freshly sorted bone marrow prepro-B or pro-B cells with TRIzol (Invitrogen, Carlsbad, CA). Next, 50 ng total RNA was applied for first-strand cDNA synthesis using the SuperScript II First-Strand Synthesis Kit (Invitrogen). Serially diluted cDNA was used for 28-32 cycles of PCR with gene-specific primer pairs (Supplemental Table 1) . PCR products were then separated in 1.5% agarose gel and visualized by a Dyversity imaging system (Syngene, Frederick, MD).
Statistical analysis
The Student t test, assuming unequal variances between the two samples, was applied to determine the significance of difference between experimental mice and their littermates. The p values were considered significant when the probability of a difference was ,0.05.
Results
Sox4 is required for pro-B cell development
To determine at which step in normal B cell development Sox4 is first required, we generated mouse strains harboring the . Gating strategies and abbreviations are the same as in Fig. 1 , and n = 3-5 mice per group unless otherwise specified. 
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Vav-Cre embryos (Fig. 2E) . This result suggested that deletion of the Sox4 gene in embryonic HSCs resulted in the abrogation of fetal liver pro-B cells and that this abrogation was responsible for the B cell deficiency in fetal liver cell-reconstituted adult bone marrow and in vitro culture.
To exclude the possibility of incomplete or escape of Sox4 deletion in the residual B cells in Sox4 fl/fl Vav-Cre mice, we sorted out the minute populations of prepro-B cells and pro-B cells and analyzed the Sox4 mRNA levels. Sox4 mRNA was not detectable in bone marrow fraction A cells (Fig. 3A) or residual pro-B cells (Fig. 3B) (Fig. 3C, left) . We also crossed the Sox4 fl/fl
Vav-Cre mice with Rosa26-enhanced yellow fluorescent protein (EYFP) Cre reporter mice to assess Cre activity in residual B cells. It was found that .90% of bone marrow prepro-B (fraction A) cells and .95% of peripheral blood residual B220 + CD19 + B cells were EYFP positive (Fig. 3D, 3E) 
Sox4 is vital for the survival of pro-B and pre-B cells
To measure apoptosis in minute populations of B cells, particularly in mice with B cell deficiency caused by Sox4 deletion, we used highly sensitive multicolor flow cytometry with Annexin V staining (49, 50) . Annexin V staining may vary in B cells with a different status of activation (51), but is a reliable marker for apoptosis when comparing cells at similar stages in development (52, 53) . As shown in Vav-Cre mice had a frequency of apoptosis comparable to that in controls. These results suggested that Sox4 was crucial for maintaining the survival of pro-B and pre-B cells but not required for the survival of later stage B cells.
Sox4 cooperates with the c-Kit signaling pathway to regulate pro-B cell survival
To find out whether Sox4 exerts its function by regulating the genes known to be critical in early B cell development, we sorted out the small number of residual pro-B cells and characterized the expression of these genes by semiquantitative RT-PCR. Of the genes studied, including IL-7r, Cxcr4, E2a, Ebf1, Pax5, Foxp1, Stat5a, Ezh2, and Rag1, none showed a significant difference in expression between Sox4 fl/fl Vav-Cre mice and their control littermates (Fig. 4B) . Because Sox4 deficiency caused pro-B cell apoptosis, we also determined the mRNA levels of two antiapoptotic genesBcl2 and Mcl1, which were also known to be involved in early B cell development-and found no significant difference in them, either (Fig. 4B) . However, the possibility still existed that Sox4 regulates some of these gene products at the posttranscriptional level.
We Fig. 4C ). Although deletion of one copy of the Sox4 gene (Sox4 fl/+ Vav-Cre) resulted in only minimal apoptosis of c-Kit + pro-B cells (Fig. 4D, left) , it caused nearly three times the frequency of apoptosis in pre-B cells compared with control (3.36% versus 9.65%; Fig. 4D, right) , which did not express c-Kit. We hypothesized that c-Kit compensates for the deleterious effect of Sox4 deletion in pro-B cells. We administered 100 mg of the c-Kit inhibitor imatinib by i. Because the frequency of apoptosis in Sox4-deficient pro-B cells was significantly increased and lack of the antiapoptosis protein Bcl2 was reported to increase the susceptibility of pro-B cells to proapoptotic agents (55, 56) , we analyzed the level of Bcl2 protein in Sox4-deficient pro-B cells. Although Bcl2 mRNA did not show significant change (Fig. 4B) + bone marrow B cells (Fig. 5A, right) . These data indicated that the proapoptotic effect of Sox4 deficiency in pro-B cells was associated with reduction of Bcl2 at the protein level.
Forced expression of Bcl2 in Bcl2-Tg mice has been shown to restore hematopoietic cell development in a number of gene- fl/fl Vav-Cre mice, with or without Bcl2-Tg, showed that the increase in the number of B cells in Bcl2-Tg mice was associated with a reduction in the frequency of apoptosis in pro-B cells (Fig.  5B ) and pre-B cells (Fig. 5C) , whereas the frequency of apoptosis in immature and mature B cells remained essentially the same (Fig. 5D) . The rescued B cells did not have detectable Sox4 mRNA expression by semiquantitative RT-PCR (Fig. 5E) , and real-time RT-PCR showed a 2632-fold reduction in Sox4 mRNA levels in pro-B cells of Sox4 fl/fl Vav-Cre mice (Fig. 3C, right) , yet the rescued pro-B cells retained the normal expression pattern of critical B cell development genes listed in Fig. 4B . These results suggested that forced Bcl2 expression could partially restore B cell development by reducing apoptosis caused by Sox4 deficiency. Noticeably, bone marrow IgM + late stage B cells (fractions E and F) and peripheral blood B220 + CD19 + B cells were increased in number as well (Fig. 5D , Table I ), suggesting that the rescued pro-B cells could pass through the checkpoint from pre-BCR + pre-B cells to BCR + immature and mature B cells without the function of Sox4.
Discussion
In this study, we investigated the role of Sox4 in B cell development by conditionally knocking out the Sox4 gene in HSCs. We found that deletion of Sox4 markedly reduced the number of pro-B cells associated with an increased frequency of apoptosis, indicating that Sox4 was essential for the survival of pro-B cells. Our data also suggested that Sox4 functionally interacted with c-Kit and Bcl2 in protecting pro-B cells from apoptosis.
In the stepwise analysis of B cell development, depletion of fraction B pro-B cells is the earliest major change caused by Sox4 deficiency. In Sox4 fl/fl Vav-Cre mice, although the number of Lin 2 c-Kit + Sca-1 + HSC-enriched cells was moderately decreased, no significant change was noted in the number of CLPs and prepro-B cells. Thus, the nearly complete absence of pro-B cells was unlikely to have resulted from a decrease in the earlier stage cells. Nevertheless, to confirm that heterogeneity in the fraction A population did not obscure the B lineage subset, we measured the expression of various markers representing individual subsets within it, including AA4.1 for B cells (45), NK1.1 for NK cells, and CD11c for pDCs (46, 47) . We found that the size of each individual subset was not significantly altered in the absence of Sox4. Therefore, marked reduction in the number of pro-B cells is the major cause for deficiency of downstream B cells. Our data also showed that deletion of Sox4 in embryonic HSCs caused fetal liver pro-B cell deficiency in Sox4 fl/fl Vav-Cre mice and that deletion of Sox4 in adult bone marrow resulted in pro-B cell deficiency in Sox4 fl/fl Vav-Cre mice. We conclude, therefore, that Sox4 is required for B cell development in both the fetal liver and adult bone marrow and that its deficiency causes pro-B cell abrogation.
Although controversy exists in the literature, Sox4 appears to be a cell survival factor. This function has been postulated for neural cells during spinal cord development (35) and for the development of late sympathetic ganglia (31, 33) . In the current study, a significant increase in the frequency of apoptosis was observed in residual pro-B and pre-B cells in Sox4 fl/fl Vav-Cre mice. However, the frequency of apoptosis in prepro-B cells in Sox4 fl/fl Vav-Cre mice was not significantly different from that in control mice. Likewise, the status of apoptosis of immature and mature B cells was not affected by Sox4 deletion. Thus, during B cell development, Sox4 is required for the survival of pro-B and pre-B cells, but unlikely for B cells in other stages.
As a transcription factor, Sox4 is expected to be part of the hierarchy of multiple transcription factors that control early B cell development, including Ebf1, E2A, and Pax5. However, the mRNA levels of these transcription factors and several other proteins such as CXCR4 and IL-7R that are critical in early B cell development were not changed in Sox4-deficient pro-B cells, suggesting that the expression of these genes was not directly regulated by Sox4 at the transcription level. Nevertheless, it could not be ruled out that Sox4 might indirectly regulate these gene products at the protein level. Although the Sox4 transcriptional program remains to be elucidated, our data show that c-Kit signaling and Bcl2 function are important in the control of pro-B cell survival supported by Sox4.
The stem cell factor/c-Kit axis, through activation of Src, PI3K, and JAK/STAT, provides proliferation and survival signals to pro-B cells to ensure their proper development (57) . C-Kit is a pro-B cell marker, and c-Kit-positive pro-B cells were diminished upon Sox4 deletion. We demonstrated that treatment with the tyrosine kinase inhibitor imatinib could sensitize the apoptotic effect of Sox4 deficiency in pro-B cells in vivo. Given the role of c-Kit in early B cell development, this sensitization most likely had resulted from the inhibition of c-Kit by imatinib and reflected functional cooperation of Sox4 and c-Kit in this process. This idea is supported by our findings that the level of Src phosphorylation (Y416) was lower in pro-B cells of Sox4 fl/fl Vav-Cre mice than of Sox4 fl/+ Vav-Cre mice. Src kinase is a downstream signaling component of the c-Kit pathway, and its signaling is critical in pro-B cell development (28) . Src phosphorylation (Y416) has been reported to provide survival signals, and targeting Src activation could enhance apoptosis in multiple cell lines treated with proapoptotic agents (58, 59) . In our study, the lower Src phosphorylation (Y416) in the Sox4 fl/fl Vav-Cre mice indicates that c-Kit/Src signaling is weakened in the absence of Sox4.
Bcl2 was reported to be highly expressed in normal bone marrow pro-B cells (17) . Deficiency in B cell development caused by disruption of a number of genes can be completely or partially rescued by a Bcl2 transgene (24) . We also detected a high level of Table I To conclude, we report that deletion of the Sox4 gene in HSCs causes severe deficiencies of pro-B and later stage B cells. Sox4 promotes survival during early B cell development in bone marrow and may functionally interact with c-Kit and Bcl2 in this process. Inhibition of c-Kit with imatinib sensitizes the apoptotic effect of Sox4 deficiency, and forced Bcl2 expression could partially rescue B cell development in the absence of Sox4.
